NASDAQ: NRC - National Research Corporation

Yield per half year: -33.17%
Dividend yield: +2.06%
Sector: Healthcare

Share chart National Research Corporation

Extended chart Simple chart
Financial Markets by TradingView

About National Research Corporation

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

more details
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 1997-10-10
ISIN US6373722023
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.72
Дивиденд ао 0.48
Сайт https://www.nrchealth.com
Цена ао 14.59
Change price per day: +1.64% (14.59)
Change price per week: -1.85% (15.11)
Change price per month: -14.03% (17.25)
Change price per 3 month: -16.64% (17.79)
Change price per half year: -33.17% (22.19)
Change price per year: -62.38% (39.42)
Change price per 3 year: -60.76% (37.79)
Change price per 5 year: -78.48% (68.92)
Change price per 10 year: 0% (14.83)
Change price per year to date: -13.63% (17.17)
All parameters

Underestimation

Title Value Grade
P/S 6.63 1
P/BV 20.11 1
P/E 31.79 5
EV/EBITDA 22.12 5
Total: 4.13

Efficiency

Title Value Grade
ROA, % 25.3 8
ROE, % 63.26 10
Total: 7.33

Dividends

Title Value Grade
Div yield, % 2.06 5.15
DSI 0.8571 8.57
Total: 5.64

Debt

Title Value Grade
Debt/EBITDA 0.8109 9
Total: 8.4

Growth impulse

Title Value Grade
Yield Revenue, % 16.08 3
Yield Ebitda, % -4.4 0
Yield EPS, % -0.3763 0
Total: 0.6
More

More

Institutions Volume Share, %
Kayne Anderson Rudnick Investment Management LLC 2881464 12.08
Blackrock Inc. 1065585 4.47
Morgan Stanley 943710 3.96
Vanguard Group Inc 934644 3.92
Conestoga Capital Advisors, LLC 780806 3.27
Dimensional Fund Advisors LP 636402 2.67
QV Investors Inc. 395102 1.66
Renaissance Technologies, LLC 373584 1.57
Geode Capital Management, LLC 356305 1.49
State Street Corporation 342475 1.44

ETFShare, %Profitability for 1 year, %Dividends, %
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.06502 18.2 1.66828
iShares Russell 2000 Growth ETF 0.02498 38.04 0.6026
iShares Morningstar Small-Cap Growth ETF 0.01365 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.01365 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.00669 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00669 391.25 1.60498
iShares Russell 3000 ETF 0.00055 24.83 1.43482
SPDR Portfolio Europe ETF 0.00011 8.94 3.66537
Dimensional International Core Equity 2 ETF 0.00006 6.52 3.69996
0.01126.61.75



Head Job title Payment Year of birth
Mr. Michael D. Hays Founder, CEO, President & Director 131.11k 1955 (70 years)
Ms. Helen L. Hrdy Chief Customer Officer 291.51k 1965 (60 years)
Mr. Jon Boumstein Chief Delivery Officer N/A
Megan Charko Senior Manager of Content Marketing N/A
Mr. Christophe Louvion Chief Product & Technology Officer N/A 1973 (52 years)
Mr. Andy Monnich Chief Corporate Development Officer N/A 1976 (49 years)
Mr. Jason Hahn Chief Revenue Officer N/A 1972 (53 years)
Ms. Linda Stacy Secretary N/A
Ms. Vinitha Ramnathan Chief Product Officer

Address: United States, Lincoln. NE, 1245 Q Street - open in Google maps, open in Yandex maps
Website: https://www.nrchealth.com